Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sonnet BioTherapeutics I...

    NASDAQ: SONN · Real-Time Price · USD
    1.25
    0.09 (7.76%)
    At close: Jun 06, 2025, 3:59 PM
    1.25
    0.00%
    After-hours: Jun 06, 2025, 04:00 PM EDT

    Sonnet BioTherapeutics Statistics

    Share Statistics

    Sonnet BioTherapeutics has 3.17M shares outstanding. The number of shares has increased by -1.5% in one year.

    Shares Outstanding

    n/a
    		 3.17M

    Shares Change (YoY)

    n/a
    		 -1.5%

    Shares Change (QoQ)

    n/a
    		 1.94%

    Owned by Institutions (%)

    n/a
    		 0.05%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 437

    FTD / Avg. Volume

    n/a
    		 1.12%

    Short Selling Information

    The latest short interest is 98.09K, so 3.1% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 98.09K

    Short % of Shares Out

    n/a
    		 3.1%

    Short % of Float

    n/a
    		 3.12%

    Short Ratio (days to cover)

    n/a
    		 3.93

    Valuation Ratios

    The PE ratio is -0.59 and the forward PE ratio is -0.01. Sonnet BioTherapeutics's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.59

    Forward PE

    n/a
    		 -0.01

    PS Ratio

    n/a
    		 235.35

    Forward PS

    n/a
    		 1076

    PB Ratio

    n/a
    		 -9.02

    P/FCF Ratio

    n/a
    		 -0.51

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sonnet BioTherapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.66, with a Debt / Equity ratio of -0.27.

    Current Ratio

    n/a
    		 0.66

    Quick Ratio

    n/a
    		 0.66

    Debt / Equity

    n/a
    		 -0.27

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,432.77

    Profits Per Employee

    n/a
    		 $-572,094.77

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -91.16% in the last 52 weeks. The beta is 0.94, so Sonnet BioTherapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.94

    52-Week Price Change

    n/a
    		 -91.16%

    50-Day Moving Average

    n/a
    		 1.28

    200-Day Moving Average

    n/a
    		 2.85

    Relative Strength Index (RSI)

    n/a
    		 40.49

    Average Volume (20 Days)

    n/a
    		 39,004

    Income Statement

    In the last 12 months, Sonnet BioTherapeutics had revenue of 18.63K and earned -7.44M in profits. Earnings per share was -11.35.

    Revenue

    n/a
    		 18.63K

    Gross Profit

    n/a
    		 18.63K

    Operating Income

    n/a
    		 -11.85M

    Net Income

    n/a
    		 -7.44M

    EBITDA

    n/a
    		 -11.77M

    EBIT

    n/a
    		 -11.85M

    Earnings Per Share (EPS)

    n/a
    		 -11.35
    Full Income Statement

    Balance Sheet

    The company has 149.46K in cash and 130.86K in debt, giving a net cash position of 18.59K.

    Cash & Cash Equivalents

    n/a
    		 149.46K

    Total Debt

    n/a
    		 130.86K

    Net Cash

    n/a
    		 18.59K

    Retained Earnings

    n/a
    		 -117.68M

    Total Assets

    n/a
    		 3.84M

    Working Capital

    n/a
    		 83.99K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.61M and capital expenditures 0, giving a free cash flow of -8.61M.

    Operating Cash Flow

    n/a
    		 -8.61M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -8.61M

    FCF Per Share

    n/a
    		 -13.14
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -63617.91% and -39929.3%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -63617.91%

    Pretax Margin

    n/a
    		 -39929.3%

    Profit Margin

    n/a
    		 -39929.3%

    EBITDA Margin

    n/a
    		 -63171.67%

    EBIT Margin

    n/a
    		 -63617.91%

    FCF Margin

    n/a
    		 -46213.48%

    Dividends & Yields

    SONN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SONN is $20, which is 1624.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $20

    Price Target Difference

    n/a
    		 1624.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 30, 2024. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 Sep 30, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 -56.21

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist